These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 32378703

  • 21. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes.
    Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL.
    J Pediatr; 2013 Nov; 163(5):1422-6.e1-4. PubMed ID: 23896191
    [Abstract] [Full Text] [Related]

  • 22. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C, Chanthavanich P, Limkittikul K, Siegrist CA, Wijagkanalan W, Chinwangso P, Petre J, Hong Thai P, Chauhan M, Viviani S.
    Hum Vaccin Immunother; 2017 Jan 02; 13(1):136-143. PubMed ID: 27686283
    [Abstract] [Full Text] [Related]

  • 23. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV, Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2006 Mar 24; 55(RR-3):1-34. PubMed ID: 16557217
    [Abstract] [Full Text] [Related]

  • 24. Increasing postpartum rate of vaccination with tetanus, diphtheria, and acellular pertussis vaccine by incorporating pertussis cocooning information into prenatal education for group B streptococcus prevention.
    Cheng PJ, Huang SY, Su SY, Peng HH, Chang CL.
    Vaccine; 2015 Dec 16; 33(51):7225-7231. PubMed ID: 26549365
    [Abstract] [Full Text] [Related]

  • 25. Predictors of tetanus, diphtheria, acellular pertussis and influenza vaccination during pregnancy among full-term deliveries in a medically underserved population.
    Doraivelu K, Boulet SL, Biswas HH, Adams JC, Haddad LB, Jamieson DJ.
    Vaccine; 2019 Sep 24; 37(41):6054-6059. PubMed ID: 31471152
    [Abstract] [Full Text] [Related]

  • 26. Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study.
    Sancovski M, Mesaros N, Feng Y, Ceregido MA, Luyts D, De Barros E.
    Hum Vaccin Immunother; 2019 Sep 24; 15(12):2873-2881. PubMed ID: 31216218
    [Abstract] [Full Text] [Related]

  • 27. Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy - 16 States and New York City, 2011.
    Ahluwalia IB, Ding H, D'Angelo D, Shealy KH, Singleton JA, Liang J, Rosenberg KD, Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2015 May 22; 64(19):522-6. PubMed ID: 25996094
    [Abstract] [Full Text] [Related]

  • 28. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population.
    Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ, Vaccine Safety Datalink (VSD) Team.
    Clin Infect Dis; 2013 Feb 22; 56(3):315-21. PubMed ID: 23196953
    [Abstract] [Full Text] [Related]

  • 29. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
    Sricharoenchai S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, Dhitavat J, Pitisuthitham A, Phongsamart W, Boonnak K, Lapphra K, Sabmee Y, Wittawatmongkol O, Chinwangso P, Poredi IK, Petre J, Thai PH, Viviani S.
    Lancet Infect Dis; 2018 Jan 22; 18(1):58-67. PubMed ID: 29066131
    [Abstract] [Full Text] [Related]

  • 30. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.
    Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Klein NP, Cheetham TC, Naleway AL, Lee GM, Hambidge S, Jackson ML, Omer SB, McCarthy N, Nordin JD.
    Vaccine; 2016 Feb 10; 34(7):968-73. PubMed ID: 26765288
    [Abstract] [Full Text] [Related]

  • 31. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Strassberg ER, Power M, Schulkin J, Stark LM, Mackeen AD, Murtough KL, Paglia MJ.
    Vaccine; 2018 Jul 16; 36(30):4548-4554. PubMed ID: 29907484
    [Abstract] [Full Text] [Related]

  • 32. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Fortner KB, Swamy GK, Broder KR, Jimenez-Truque N, Zhu Y, Moro PL, Liang J, Walter EB, Heine RP, Moody MA, Yoder S, Edwards KM.
    Vaccine; 2018 Oct 08; 36(42):6354-6360. PubMed ID: 30219367
    [Abstract] [Full Text] [Related]

  • 33. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.
    J Pediatr; 2006 Nov 08; 149(5):603-610. PubMed ID: 17095328
    [Abstract] [Full Text] [Related]

  • 34. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D, Kimmel M, Kuriyakose SO, Kostanyan L, Mesaros N.
    Vaccine; 2018 Oct 08; 36(42):6325-6333. PubMed ID: 30197282
    [Abstract] [Full Text] [Related]

  • 35. Effect of Prepregnancy Pertussis Vaccination in Young Infants.
    Maertens K, Tran TMP, Hens N, Van Damme P, Leuridan E.
    J Infect Dis; 2017 Jun 15; 215(12):1855-1861. PubMed ID: 28863468
    [Abstract] [Full Text] [Related]

  • 36. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.
    BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777
    [Abstract] [Full Text] [Related]

  • 37. Tdap vaccine attitudes and utilization among pregnant women from a high-risk population.
    Dempsey AF, Brewer SE, Sevick C, Pyrzanowski J, Mazzoni S, O'Leary ST.
    Hum Vaccin Immunother; 2016 Apr 02; 12(4):872-8. PubMed ID: 26430729
    [Abstract] [Full Text] [Related]

  • 38. Lower Risk for Dementia Following Adult Tetanus, Diphtheria, and Pertussis (Tdap) Vaccination.
    Scherrer JF, Salas J, Wiemken TL, Jacobs C, Morley JE, Hoft DF.
    J Gerontol A Biol Sci Med Sci; 2021 Jul 13; 76(8):1436-1443. PubMed ID: 33856020
    [Abstract] [Full Text] [Related]

  • 39. Prenatal Tdap immunization and risk of maternal and newborn adverse events.
    Layton JB, Butler AM, Li D, Boggess KA, Weber DJ, McGrath LJ, Becker-Dreps S.
    Vaccine; 2017 Jul 24; 35(33):4072-4078. PubMed ID: 28669620
    [Abstract] [Full Text] [Related]

  • 40. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV, Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee.
    MMWR Recomm Rep; 2006 Dec 15; 55(RR-17):1-37. PubMed ID: 17167397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.